Influenza;Influenza

Internist

Volumn 60, Issue 11, 2019, Pages 1127-1135

  Malainou, C ^a   Herold, S ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Acute respiratory distress syndrome; Influenza vaccines, seasonal; Neuraminidase inhibitors; Pneumonia, viral, influenza; Polymerase chain reaction

Indexed keywords

INFLUENZA VACCINE; SIALIDASE INHIBITOR; ANTIVIRUS AGENT; SIALIDASE;

ANTIVIRAL THERAPY; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; REVIEW; SEASONAL INFLUENZA; SYSTEMATIC REVIEW; VIRUS PATHOGENESIS; ADULT RESPIRATORY DISTRESS SYNDROME; EUROPE; MORBIDITY; PANDEMIC; VIRUS PNEUMONIA;

ANTIVIRAL AGENTS; EUROPE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MORBIDITY; NEURAMINIDASE; PANDEMICS; PNEUMONIA, VIRAL; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 85071634123     PISSN: 00209554     EISSN: 14321289     Source Type: Journal    
DOI: 10.1007/s00108-019-00670-6     Document Type: Review

References (52)

1. Ambrose CS, Levin MJ (2012) The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother 8:81–88
2. Brandes M, Klauschen F, Kuchen S et al (2013) A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell 154:197–212
3. Buda S, Prahm K, Dürrwald R et al (2018) Bericht zur Epidemiologie der Influenza in Deutschland Saison 2017/18. https://edoc.rki.de/handle/176904/5739. Zugegriffen: 10. Juni 2019
4. Casado I, Dominguez A, Toledo D et al (2018) Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study. CMAJ 190:E3–E12
5. Cassini A, Colzani E, Pini A et al (2018) Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013. Euro Surveill 23(16):17–454
6. CDC (2015) The pink book: course textbook. Epidemiology and prevention of vaccine-preventable diseases. https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/table-of-contents.pdf. Zugegriffen: 2. Juni 2019
7. Chartrand C, Leeflang MM, Minion J et al (2012) Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med 156:500–511
8. Cheng Z, Zhou J, To KK et al (2015) Identification of TMPRSS2 as a susceptibility gene for severe 2009 pandemic A(H1N1) influenza and A(H7N9) influenza. J Infect Dis 212:1214–1221
9. Ciancanelli MJ, Abel L, Zhang SY et al (2016) Host genetics of severe influenza: from mouse Mx1 to human IRF7. Curr Opin Immunol 38:109–120
10. Dunning J, Blankley S, Hoang LT et al (2018) Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza. Nat Immunol 19:625–635
11. ECDC (2018) Seasonal influenza, 2017–2018. Annual epidemiological report for 2017. https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2017-seasonal-influenza.pdf. Zugegriffen: 2. Juni 2019
12. ECDC (2017) Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza—review of recent systematic reviews and meta-analyses. https://ecdc.europa.eu/sites/portal/files/documents/Scientific-advice-neuraminidase-inhibitors-2017.pdf. Zugegriffen: 13. Juni 2019
13. Edouard S, Million M, Bachar D et al (2018) The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens. Eur J Clin Microbiol Infect Dis 37:1725–1733
14. Ewig S, Hoffken G, Kern WV et al (2016) Management of adult community-acquired pneumonia and prevention – update 2016. Pneumologie 70:151–200
15. Giannella M, Rodriguez-Sanchez B, Roa PL et al (2012) Should lower respiratory tract secretions from intensive care patients be systematically screened for influenza virus during the influenza season? Crit Care 16(3):R104
16. Hayden FG, Sugaya N, Hirotsu N et al (2018) Baloxavir Marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med 379:913–923
17. Herold S, Becker C, Ridge KM et al (2015) Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur Respir J 45:1463–1478
18. Hogner K, Wolff T, Pleschka S et al (2013) Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. Plos Pathog 9(2):e1003188
19. Jain S, Self WH, Wunderink RG et al (2015) Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med 373:415–427
20. Jefferson T, Jones MA, Doshi P et al (2014) Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2014(4):CD8965
21. Kwong JC, Schwartz KL, Campitelli MA et al (2018) Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med 378:345–353
22. Lehners N, Tabatabai J, Prifert C et al (2016) Long-term shedding of influenza virus, Parainfluenza virus, respiratory Syncytial virus and Nosocomial epidemiology in patients with hematological disorders. PLoS ONE 11(2):e148258
23. Lehnert R, Pletz M, Reuss A et al (2016) Antiviral medications in seasonal and pandemic influenza. Dtsch Arztebl Int 113:799–807
24. Lessler J, Reich NG, Brookmeyer R et al (2009) Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 9:291–300
25. Lim HK, Huang SXL, Chen J et al (2019) Severe influenza pneumonitis in children with inherited TLR3 deficiency. J Exp Med. 10.1084/jem.20181621. [Epub ahead of print]
26. Lopez Roa P, Rodriguez-Sanchez B, Catalan P et al (2012) Diagnosis of influenza in intensive care units: lower respiratory tract samples are better than nose-throat swabs. Am J Respir Crit Care Med 186:929–930
27. Louie JK, Yang S, Acosta M et al (2012) Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. Clin Infect Dis 55:1198–1204
28. Mertens T (2015) Influenza – Prophylaxe und Therapie: Für Neuraminidasehemmer gibt es noch keinen Ersatz. Dtsch Arztebl Int 112:464
29. Morens DM, Taubenberger JK (2018) Influenza Cataclysm, 1918. N Engl J Med 379:2285–2287
30. Muthuri SG, Venkatesan S, Myles PR et al (2014) Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2:395–404
31. Neumann G, Noda T, Kawaoka Y (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459:931–939
32. Nichol KL, Nordin JD, Nelson DB et al (2007) Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 357:1373–1381
33. Oved K, Cohen A, Boico O et al (2015) A novel host-proteome signature for distinguishing between acute bacterial and viral infections. PLoS ONE 10(3):e120012
34. Pauly MD, Procario MC, Lauring AS (2017) A novel twelve class fluctuation test reveals higher than expected mutation rates for influenza A viruses. Elife 6:e26437
35. Peteranderl C, Herold S, Schmoldt C (2016) Human influenza virus infections. Semin Respir Crit Care Med 37:487–500
36. Planet PJ, Parker D, Cohen TS et al (2016) Lambda interferon restructures the nasal Microbiome and increases susceptibility to staphylococcus aureus Superinfection. MBio 7(1):e1939–15
37. RKI (2018) Empfehlungen der Ständigen Impfkommission (STIKO) beim Robert Koch-Institut-2018–2019. Epidemiol Bull 34:342–348
38. RKI (2018) OKaPII-Studie zur Influenza-Impfung: Impfquoten und Impfmotivation bei Klinikpersonal in der Influenza-Saison 2016/2017. Epidemiol Bull 32:313–323
39. RKI (2018) Wissenschaftliche Begründung für die Empfehlung des quadrivalenten saisonalen Influenzaimpfstoffs. Epidemiol Bull 02:20–34
40. RKI ((2018) Aktuelles aus der KV-Impfsurveillance-Impfquoten ausgewählter Schutzimpfungen in Deutschland. Epidemiol Bull 1:1–18
41. Ruf BR, Knuf M (2014) The burden of seasonal and pandemic influenza in infants and children. Eur J Pediatr 173:265–276
42. Schauwvlieghe A, Rijnders BJA, Philips N et al (2018) Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med 6:782–792
43. Tellier R (2006) Review of aerosol transmission of influenza A virus. Emerg Infect Dis 12:1657–1662
44. Uyeki TM, Bernstein HH, Bradley JS et al (2018) Clinical practice guidelines by the infectious diseases society of america: 2018 update on diagnosis, treatment, Chemoprophylaxis, and institutional outbreak management of seasonal Influenzaa. Clin Infect Dis 68:e1–e47
45. van Houten CB, de Groot JAH, Klein A et al (2017) A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study. Lancet Infect Dis 17:431–440
46. von Baum H, Schweiger B, Welte T et al (2011) How deadly is seasonal influenza-associated pneumonia? The German competence network for community-acquired pneumonia. Eur Respir J 37:1151–1157
47. Weinberger DM, Harboe ZB, Viboud C et al (2014) Pneumococcal disease seasonality: incidence, severity and the role of influenza activity. Eur Respir J 43:833–841
48. WHO (2019) WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. https://www.who.int/csr/resources/publications/swineflu/h1n1_guidelines_pharmaceutical_mngt.pdf. Zugegriffen: 4. Juli 2019
49. WHO (2019) WHO recommendations on the composition of influenza virus vaccines. 1998–2019. https://www.who.int/influenza/vaccines/virus/recommendations/en/. Zugegriffen: 26. Juni 2019
50. WHO (2018) Fact sheet avian and other zoonotic influenza viruses. https://www.who.int/news-room/fact-sheets/detail/influenza-(avian-and-other-zoonotic). Zugegriffen: 11. Juni 2019
51. Yamayoshi S, Kawaoka Y (2019) Current and future influenza vaccines. Nat Med 25:212–220
52. Yin M, Huang L, Zhang Y et al (2018) Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysis. Expert Rev Vaccines 17:653–663